Irvine-based drug maker Allergan Inc. said Wednesday that the Food and Drug Administration approved its flagship Botox for treating a form of overactive bladder. The FDA said that Botox can be ...
U.S. drug regulators approved Allergan's Botox for treating a specific kind of overactive bladder on Wednesday, setting the stage for wider use of the popular wrinkle treatment in those with bladder ...
Stocktwits on MSN
IBRX stock jumps overnight after major FDA review win for Anktiva in bladder cancer
The FDA will review the expansion of Anktiva plus BCG to patients with papillary-only bladder cancer, with a final decision expected by Jan.6, 2027. ・The acceptance reversed last year’s FDA refusal-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results